RM Bergenstal

2.2k total citations · 2 hit papers
10 papers, 1.7k citations indexed

About

RM Bergenstal is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, RM Bergenstal has authored 10 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in RM Bergenstal's work include Diabetes Management and Research (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diabetes Treatment and Management (4 papers). RM Bergenstal is often cited by papers focused on Diabetes Management and Research (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diabetes Treatment and Management (4 papers). RM Bergenstal collaborates with scholars based in United States, United Kingdom and Canada. RM Bergenstal's co-authors include John B. Buse, Matthias Nauck, Anne L. Peters, SE Inzucchi, Απόστολος Τσάπας, M. Diamant, Eleuterio Ferrannini, Richard C. Wender, Matthews Dr and M. E Miller and has published in prestigious journals such as Diabetes Care, Diabetologie und Stoffwechsel and BMJ.

In The Last Decade

RM Bergenstal

9 papers receiving 1.6k citations

Hit Papers

The association between symptomatic, severe hypoglycaemia... 2010 2026 2015 2020 2010 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
    2010 719 citations M. E Miller, RM Bergenstal et al. BMJ profile →
  2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
    2013 661 citations SE Inzucchi, RM Bergenstal et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RM Bergenstal United States 4 1.6k 380 363 265 117 10 1.7k
M. E Miller United States 2 995 0.6× 151 0.4× 175 0.5× 221 0.8× 76 0.6× 4 1.1k
Santiago Tofé Spain 12 1.0k 0.6× 482 1.3× 339 0.9× 43 0.2× 155 1.3× 43 1.3k
Bipin Sethi India 12 952 0.6× 485 1.3× 313 0.9× 52 0.2× 72 0.6× 44 1.2k
Matthew Wintle United States 12 1.4k 0.9× 637 1.7× 582 1.6× 64 0.2× 163 1.4× 18 1.6k
Francis C. C. Chow Hong Kong 14 765 0.5× 369 1.0× 247 0.7× 84 0.3× 118 1.0× 28 1.1k
Ludger Rose Germany 15 1.3k 0.8× 573 1.5× 450 1.2× 157 0.6× 104 0.9× 33 1.5k
Sarah Nethercott United Kingdom 5 765 0.5× 194 0.5× 175 0.5× 66 0.2× 88 0.8× 10 1.0k
Kerensa Thorne United Kingdom 6 965 0.6× 239 0.6× 217 0.6× 120 0.5× 102 0.9× 13 1.4k
Zin Zin Htike United Kingdom 10 804 0.5× 365 1.0× 283 0.8× 44 0.2× 103 0.9× 14 924
Aliza Rozenberg Israel 13 663 0.4× 206 0.5× 266 0.7× 89 0.3× 46 0.4× 26 753

Countries citing papers authored by RM Bergenstal

Since Specialization
Citations

This map shows the geographic impact of RM Bergenstal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RM Bergenstal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RM Bergenstal more than expected).

Fields of papers citing papers by RM Bergenstal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RM Bergenstal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RM Bergenstal. The network helps show where RM Bergenstal may publish in the future.

Co-authorship network of co-authors of RM Bergenstal

This figure shows the co-authorship network connecting the top 25 collaborators of RM Bergenstal. A scholar is included among the top collaborators of RM Bergenstal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RM Bergenstal. RM Bergenstal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Goldenberg, Ronald, et al.. (2021). Effect of Insulin Degludec U100 vs Insulin Glargine U100 on Time in Range in Patients with Type 2 Diabetes at Risk of Hypoglycaemia. Diabetologie und Stoffwechsel. 2 indexed citations
3.
4.
Jacob, Stephan, J Lüdemann, Kirstine Brown‐Frandsen, et al.. (2017). Liraglutid und renale Endpunkte bei Typ 2 Diabetes: Ergebnisse der LEADER Studie. Diabetologie und Stoffwechsel. 12(S 01). S1–S84. 3 indexed citations
5.
Ziemen, M., et al.. (2015). Glycaemic control and hypoglycaemia with new insulin glargine 300 U/mL in people with type 1 diabetes (EDITION 4). Diabetologie und Stoffwechsel. 10(S 01). 1 indexed citations
6.
Jeandidier, N., RM Bergenstal, M. Ziemen, et al.. (2014). New insulin glargine 300 U/ml: efficacy and safety of flexible vs fixed dosing intervals in people with type 2 diabetes mellitus. 5 indexed citations
7.
Inzucchi, SE, RM Bergenstal, John B. Buse, et al.. (2013). Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379. Diabetes Care. 36(2). 490–490. 661 indexed citations breakdown →
8.
Bergenstal, RM, et al.. (2012). Insulin Analogs. 12(10). 14–15. 1 indexed citations
9.
10.
Miller, M. E, et al.. (2010). The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 340(jan08 1). b4909–b4909. 719 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. E Miller Breakdown of academic impact, for papers by Santiago Tofé Breakdown of academic impact, for papers by Bipin Sethi Breakdown of academic impact, for papers by Matthew Wintle Breakdown of academic impact, for papers by Francis C. C. Chow Breakdown of academic impact, for papers by Ludger Rose Breakdown of academic impact, for papers by Sarah Nethercott Breakdown of academic impact, for papers by Kerensa Thorne Breakdown of academic impact, for papers by Zin Zin Htike Breakdown of academic impact, for papers by Aliza Rozenberg
Rankless by CCL
2026